Resources
For the latest in discovery & development, sign up for our monthly newsletter to be among the first to receive
exclusive insights, in-depth market analyses, and expert articles directly to your inbox
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Discovery & Automate 2024
Paving the Way For Animal Free Models by Leveraging 3D Cell Culture, Organoids & Organ Modelling
A Concise Report Featuring Insights From The Prominent Thought Leaders Of 3D Cell Culture & Organ Modelling 2024
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Organ Modelling
Differentiation of embryonic and induced pluripotent stem cells
Pluripotent stem cells possess the capacity for indefinite self-renewal and the potential to differentiate into all adult cell types of the three primary germ layers.
Pharma Data
Big Data Workplan for 2022 to 2025
The EMA’s Big Data Steering Group has released its third workplan outlining the key actions to be delivered between 2022 and 2025.
Medicinal Chemistry
Automation Experts Discuss New Platform for Synthesis in Organic Chemistry
Our Discussion Group featured expert conversation on automation and synthesis from software to hardware, key challenges, and end goals.
Gene Discovered to Drive Anxiety Could Prove an Effective Drug Target
The discovery could be a game-changer for the many people that suffer from anxiety related mental health disorders.
Pharma Data
Emerging Trends and Risks in Clinical Data Management
Looking to the next few years of data management in clinical trials, hybrid models which interpolate AI and ML approaches to assist trial coordinators will increasingly become the new normal.
Pharma Data
Leveraging Compound and Therapeutic Antibody Analytical Data
Analytical data is a key tool which can be leveraged to augment digital drug discovery if data workflows are properly implemented.
Positive Results Achieved from Phase III Trial of MDMA-Assisted Therapy
Significant findings after the Schedule I controlled drug completes Phase III clinical trial for PTSD patients.
Molecular Drug Design
FDA Release New Guidance for Modifications to AI/ML-Enabled Devices
The FDA has proposed new guidance which favours a science-based approach for AI/ML-Enabled devices to be modified and improved more quickly.
Discovery of Fentanyl Vaccine Called “Game Changer” with Some Sceptical
The antibody-based vaccine has been successful in rat models but has had critics who would rather see a focus on harm reduction.
Target Discovery
Addressing Specific Targets and Dealing with Target Engagement
The panel discussion from Discovery US 2022, investigates into new technologies for target engagement and expanding the chemical space.
Pharma Data
FAIR Data Principles and Use Cases in Pharma
FAIR data principles aim to standardise and enhance the management of scientific data through unique identifiers and standardised protocols. The gradual implementation of these principles can improve research efficiency, facilitating better data utilisation by both humans and machines.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things discovery